TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33231489

Group type: EXPERIMENTAL
Intervention: AMG 301 210 mg every 4 weeks
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: AMG 301 420 mg every 2 weeks
Number of subjects: 343

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 343
Study: 34563992

Group type: EXPERIMENTAL
Intervention: TACE with cisplatin
Number of subjects: 455

Group type: COMPARATOR
Intervention: TACE with epirubicin
Number of subjects: 455
Study: 36018625

Group type: EXPERIMENTAL
Intervention: eHealth program with online education videos and video consultations
Number of subjects: 280

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 280
Study: 32106721

Group type: EXPERIMENTAL
Intervention: n-BiPAP
Number of subjects: 149

Group type: COMPARATOR
Intervention: NIPPV
Number of subjects: 149
Study: 32882355

Group type: EXPERIMENTAL
Intervention: Caregivers' ratings of patient's physical distress at EOL
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Caregivers' ratings of patient's psychological distress at EOL
Number of subjects: 168
Study: 35940353

Group type: EXPERIMENTAL
Intervention: Oxycodone group (10 mg extended-release oxycodone hydrochloride)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Oxycodone group
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study: 34256830

Group type: EXPERIMENTAL
Intervention: Telerehabilitation (smartphone app with personalized program of resistance, balance, and daily activity training exercises)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Control (usual flow of public healthcare system)
Number of subjects: 230
Study: 35124335

Group type: EXPERIMENTAL
Intervention: One-handed chest compression technique (OHCC)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Two-handed chest compression technique (THCC)
Number of subjects: 32
Study: 36435545

Group type: EXPERIMENTAL
Intervention: Compassion exercise
Number of subjects: 24

Group type: COMPARATOR
Intervention: Neutral exercise
Number of subjects: 24
Study: 33992290

Group type: EXPERIMENTAL
Intervention: Modified Tardieu Scale (MTS) for assessing knee extensor spasticity
Number of subjects: 26
Study: 32974907

Group type: EXPERIMENTAL
Intervention: 150 mg racemic VEN
Number of subjects: 10

Group type: COMPARATOR
Intervention: 40 mg nifedipine with VEN
Number of subjects: 10
Study: 33332157

Group type: EXPERIMENTAL
Intervention: Explicit intervention using the SHAPE CODING system, once‐weekly sessions over 10 weeks
Number of subjects: 21

Group type: COMPARATOR
Intervention: Waiting control group (no intervention during the first phase)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Both groups received the intervention after crossover
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Standardized measures of grammar
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Extension and control measures of morphosyntax
Number of subjects: 21
Study: 35549744

Group type: EXPERIMENTAL
Intervention: Qualitative research contributions to trial design and conduct
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: One research team approach
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sustained and sufficient funding for qualitative research
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Shared infrastructure and resources
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mutual recognition of different methods and perspectives
Number of subjects: 0
Study: 32146876

Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Integrative Body-Mind-Spirit Intervention (I‐BMS)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 157
Study: 35810307

Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg (Group A)
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Aspirin 75 mg (Group B)
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Both Atorvastatin and Aspirin (Group C)
Number of subjects: 900

Group type: COMPARATOR
Intervention: Standard of care only (Group D)
Number of subjects: 900

Group type: COMPARATOR
Intervention: Atorvastatin vs Control (Group D)
Number of subjects: 900

Group type: COMPARATOR
Intervention: Aspirin vs Control (Group D)
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Aspirin (Group B)
Number of subjects: 900
Study: 33682997

Group type: EXPERIMENTAL
Intervention: 67% bovine milk fat and 33% vegetable fat (BOV)
Number of subjects: 20

Group type: COMPARATOR
Intervention: 100% vegetable fat (VEG)
Number of subjects: 20
Study: 33865929

Group type: EXPERIMENTAL
Intervention: PCIT-ED treatment (n = 64)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Waitlist control condition (n = 50)
Number of subjects: 114
Study: 34098039

Group type: EXPERIMENTAL
Intervention: Self-report adherence at 3 weeks
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Self-report adherence at 7 weeks
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Pill counts adherence at 3 weeks
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Pill counts adherence at 7 weeks
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Agreement between self-report and pill counts at 3 weeks
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Agreement between self-report and pill counts at 7 weeks
Number of subjects: 332
Study: 35893890

Group type: EXPERIMENTAL
Intervention: 5-week Few-Foods Diet (FFD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy food advice (Control)
Number of subjects: 0
Study: 33600874

Group type: EXPERIMENTAL
Intervention: Aerobic training (n = 75)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Control group (n = 69)
Number of subjects: 144
Study: 34538193

Group type: EXPERIMENTAL
Intervention: Unimanual mirror therapy (UMT)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Bimanual mirror therapy (BMT)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Traditional occupational therapy (TOT)
Number of subjects: 22
Study: 32459129

Group type: EXPERIMENTAL
Intervention: Sulpiride (800 mg)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 35385098

Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 0
Study: 33269670

Group type: EXPERIMENTAL
Intervention: Sexed semen (INR 340 per straw)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Sexed semen (INR 770 per straw)
Number of subjects: 210
Study: 33342939

Group type: EXPERIMENTAL
Intervention: Anagliptin
Number of subjects: 250

Group type: COMPARATOR
Intervention: Sitagliptin
Number of subjects: 250
Study: 33853806

Group type: EXPERIMENTAL
Intervention: Favipiravir
Number of subjects: 288

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 288
Study: 36170242

Group type: EXPERIMENTAL
Intervention: Fontan procedure group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 33737438

Group type: EXPERIMENTAL
Intervention: High burden of depression symptoms (BDI score ≥13 or CES-D score ≥10)
Number of subjects: 1464

Group type: EXPERIMENTAL
Intervention: Frequent GP attenders (5+ visits/year)
Number of subjects: 1464

Group type: EXPERIMENTAL
Intervention: Undiagnosed depression
Number of subjects: 1464

Group type: COMPARATOR
Intervention: Low burden of depression symptoms (BDI score <13 or CES-D score <10)
Number of subjects: 1464
Study: 36264568

Group type: EXPERIMENTAL
Intervention: Stereotactic radiosurgery (SRS)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Whole-brain radiotherapy (WBRT)
Number of subjects: 54
Study: 32279541

Group type: EXPERIMENTAL
Intervention: Dementia Care Mapping™ (DCM)
Number of subjects: 726

Group type: COMPARATOR
Intervention: Control
Number of subjects: 726
Study: 33811457

Group type: EXPERIMENTAL
Intervention: Primary HPV testing with reflex liquid-based cytology (LBC) upon a positive finding, screening interval of 48 months.
Number of subjects: 19009

Group type: COMPARATOR
Intervention: Primary LBC testing, negative returns at 24 months for LBC and again at 48 months for exit screening.
Number of subjects: 19009
Study: 32382859

Group type: EXPERIMENTAL
Intervention: PAIR technique
Number of subjects: 40

Group type: COMPARATOR
Intervention: Catheterization technique
Number of subjects: 40
Study: 35297709

Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 33216613

Group type: EXPERIMENTAL
Intervention: TRK (Thor-Ra-Nee-San-Tha-Kat) - 500 mg capsules, 2 capsules once daily before bed for 14 days
Number of subjects: 76

Group type: COMPARATOR
Intervention: Naproxen - 250 mg tablets, 2 tablets twice a day after meals for 14 days
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Cervical Range of Motion (CROM)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Pressure Pain Threshold (PPT)
Number of subjects: 76
Study: 33067769

Group type: EXPERIMENTAL
Intervention: Family Attendance (FA arm)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU arm)
Number of subjects: 63
Study: 32830416

Group type: EXPERIMENTAL
Intervention: Carbomer eye drops and polyethylene covers
Number of subjects: 24

Group type: COMPARATOR
Intervention: Carbomer eye drops only
Number of subjects: 24
Study: 34043272

Group type: EXPERIMENTAL
Intervention: Portable infrared spectrometer for rapid point-of-care detection of COVID-19 markers in saliva
Number of subjects: 57
Study: 35450891

Group type: EXPERIMENTAL
Intervention: Deep anaesthesia group (BIS 30-40)
Number of subjects: 854

Group type: COMPARATOR
Intervention: Light anaesthesia group (BIS 45-55)
Number of subjects: 854
Study: 33959989

Group type: EXPERIMENTAL
Intervention: NBSP
Number of subjects: 40

Group type: COMPARATOR
Intervention: 3LP
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 3LP + ES
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: NBSP + ES
Number of subjects: 40
Study: 32128535

Group type: EXPERIMENTAL
Intervention: Grade III central lumbar mobilization
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (light touch) intervention
Number of subjects: 21
Study: 36192656

Group type: EXPERIMENTAL
Intervention: AI algorithm for assessing basic laparoscopic simulation training exercises
Number of subjects: 369
Study: 34593124

Group type: EXPERIMENTAL
Intervention: Circulating ketone bodies (KBs) measured at 24 hours after reperfusion
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: Circulating ketone bodies (KBs) measured at presentation
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: Circulating ketone bodies (KBs) measured at 4-month follow-up
Number of subjects: 369
Study: 32756176

Group type: EXPERIMENTAL
Intervention: Yangxinshi (YXS) tablet
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 35578267

Group type: EXPERIMENTAL
Intervention: Resection and primary anastomosis with protective stoma (PS)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Resection and primary anastomosis without protective stoma (no PS)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Secondary endpoints include postoperative mortality, unplanned reinterventions, incisional surgical site infection (SSI), organ/space SSI, wound disruption, anastomotic leak, operating time, length of hospital stay, stoma at 1 year after initial surgery, quality of life, costs and quality‐adjusted life years (QALYs).
Number of subjects: 192
Study: 34148205

Group type: EXPERIMENTAL
Intervention: CT-P6
Number of subjects: 528

Group type: COMPARATOR
Intervention: trastuzumab
Number of subjects: 528
Study: 32424430

Group type: EXPERIMENTAL
Intervention: Continuation of PD-1 pathway inhibitors
Number of subjects: 216

Group type: COMPARATOR
Intervention: Discontinuation of PD-1 pathway inhibitors
Number of subjects: 216
Study: 34772330

Group type: EXPERIMENTAL
Intervention: High EPA + DHA diet (high or low sucrose)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: High ALA diet (high or low sucrose)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Chemotherapy treatment
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Liver PUFAs
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: BDNF
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control diet (no EPA + DHA, low ALA, low sucrose)
Number of subjects: 90
Study: 32348688

Group type: EXPERIMENTAL
Intervention: Strength training (ST) with vitamin C (500 mg/day) and E (180 mg/day) supplementation
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo (PLA) with polydextrose (1 g/day)
Number of subjects: 25
Study: 33635263

Group type: EXPERIMENTAL
Intervention: Acupoint catgut embedding (ACE)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Sham ACE (SHAM)
Number of subjects: 200
Study: 33027159

Group type: EXPERIMENTAL
Intervention: FAITH trial patients with displaced fractures
Number of subjects: 1079

Group type: COMPARATOR
Intervention: HEALTH trial patients
Number of subjects: 1079
Study: 616115972

Group type: COMPARATOR
Intervention: Alendronate
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Slow-release sodium fluoride (SR-NaF)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 84
Study: 34410384

Group type: EXPERIMENTAL
Intervention: Remote patient monitoring (RPM) plus an annual In‐Clinic visit
Number of subjects: 595

Group type: COMPARATOR
Intervention: In‐Clinic check‐ups alone (3-6 months)
Number of subjects: 595

Group type: EXPERIMENTAL
Intervention: Remote patient monitoring (RPM)
Number of subjects: 595
Study: 33677172

Group type: EXPERIMENTAL
Intervention: Acupuncture with low-level laser therapy (ALLLT)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Sham ALLLT (control group)
Number of subjects: 82
Study: 32652969

Group type: EXPERIMENTAL
Intervention: Alma Sana Bracelet Group
Number of subjects: 1445

Group type: EXPERIMENTAL
Intervention: Star Bracelet Group
Number of subjects: 1445

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 1445
Study: 34198351

Group type: EXPERIMENTAL
Intervention: Trabeculectomy with OloGen
Number of subjects: 40

Group type: COMPARATOR
Intervention: Trabeculectomy with Mitomycin C (MMC)
Number of subjects: 40
Study: 33795324

Group type: EXPERIMENTAL
Intervention: CPAP treatment
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control (no CPAP)
Number of subjects: 92
Study: 32989888

Group type: EXPERIMENTAL
Intervention: Inhaled methoxyflurane (3 mL)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 120
Study: 35763326

Group type: EXPERIMENTAL
Intervention: Abrocitinib 200 mg or 100 mg
Number of subjects: 548

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 548
Study: 33676595

Group type: EXPERIMENTAL
Intervention: Listerine
Number of subjects: 227

Group type: COMPARATOR
Intervention: Biotène
Number of subjects: 227
Study: 36400376

Group type: EXPERIMENTAL
Intervention: ECST (recombinant fusion protein ESAT6-CFP10)
Number of subjects: 1085

Group type: COMPARATOR
Intervention: TST (Tuberculin Skin Test)
Number of subjects: 1085

Group type: EXPERIMENTAL
Intervention: T‐SPOT.TB
Number of subjects: 1085
Study: 36269935

Group type: EXPERIMENTAL
Intervention: Concurrent/adjuvant ADT with PORT (n = 4,355)
Number of subjects: 7409

Group type: EXPERIMENTAL
Intervention: Concurrent/adjuvant ADT with WPRT (n = 3,049)
Number of subjects: 7409
Study: 33313735

Group type: EXPERIMENTAL
Intervention: Active physical therapy clinical practice guidelines (CPG) implementation strategy using education, audit, and feedback model
Number of subjects: 3300

Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 3300
Study: 34478611

Group type: EXPERIMENTAL
Intervention: Self-affirmation task
Number of subjects: 254

Group type: COMPARATOR
Intervention: Control task
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Self-affirmation and Control
Number of subjects: 254
Study: 33781053

Group type: EXPERIMENTAL
Intervention: Talazoparib 1 mg/day
Number of subjects: 33

Group type: COMPARATOR
Intervention: Chemotherapy (physician's choice)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Talazoparib
Number of subjects: 33

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 33
Study: 33181674

Group type: EXPERIMENTAL
Intervention: Flipped classroom combined with human anatomy web‐based learning system
Number of subjects: 89

Group type: COMPARATOR
Intervention: Traditional classroom teaching
Number of subjects: 89
Study: 36043569

Group type: EXPERIMENTAL
Intervention: F+Sn+HMC - 7,500 ppm F‐ / 15,000 ppm Sn2+
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Commercial acidulated phosphate fluoride gel (12,300 ppm F‐)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: F+HMC - 7,500 ppm F‐
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo - Hydroxypropyl Methylcellulose (HMC) gel
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control - no treatment
Number of subjects: 50
Study: 36055770

Group type: EXPERIMENTAL
Intervention: Moderate Spice Diet (MSD) at 3.3 g.d-1.2100 kcal-1
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: High Spice Diet (HSD) at 6.6 g.d-1.2100 kcal-1
Number of subjects: 54

Group type: COMPARATOR
Intervention: Low Spice Diet (LSD) at 0.5 g.d-1.2100 kcal-1
Number of subjects: 54
Study: 34872531

Group type: EXPERIMENTAL
Intervention: Self-referral to inpatient treatment (SRIT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nurse-led SRIT treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SRIT
Number of subjects: 0
Study: 35565722

Group type: EXPERIMENTAL
Intervention: Wheat noodle meals
Number of subjects: 8

Group type: COMPARATOR
Intervention: Rice noodle meals
Number of subjects: 8
Study: 32220917

Group type: EXPERIMENTAL
Intervention: Low-energy meal replacement diet (MRP)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Supervised aerobic exercise training
Number of subjects: 87

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 87
Study: 36254068

Group type: EXPERIMENTAL
Intervention: Multiplex PCR
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional culture methods
Number of subjects: 200
Study: 32669026

Group type: EXPERIMENTAL
Intervention: Arthroscopic exploration of the button followed by post-operative X-ray (Group B)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Post-operative X-ray to assess the position of the femoral button (Group A)
Number of subjects: 193
Study: 32925778

Group type: EXPERIMENTAL
Intervention: modified Ban-Xia-Xie-Xin-Decotion plus basic treatment
Number of subjects: 92

Group type: COMPARATOR
Intervention: basic treatment only
Number of subjects: 92
Study: 32666827

Group type: EXPERIMENTAL
Intervention: Electrical Stimulation (ES)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control
Number of subjects: 2
Study: 34597298

Group type: EXPERIMENTAL
Intervention: 2-dose regimen of 5-μg NVX-CoV2373
Number of subjects: 1288

Group type: EXPERIMENTAL
Intervention: 2-dose regimen of 25-μg NVX-CoV2373
Number of subjects: 1288

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1288
Study: 32782008

Group type: EXPERIMENTAL
Intervention: Multimodal physical treatments (manual therapy, advice, education, exercise)
Number of subjects: 108
Study: 615918822

Group type: EXPERIMENTAL
Intervention: Ranibizumab or Bevacizumab (anti-VEGF)
Number of subjects: 1183
Study: 35108031

Group type: EXPERIMENTAL
Intervention: Compression sleeves
Number of subjects: 307

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 307
Study: 32330315

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo PBMT
Number of subjects: 18
Study: 32643454

Group type: EXPERIMENTAL
Intervention: Intradermal minoxidil 5% injections
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Micro-needling
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Combination treatment (minoxidil + triamcinolone acetonide)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Negative control (observed patch)
Number of subjects: 20
Study: 32949957

Group type: EXPERIMENTAL
Intervention: Cognitive intervention (individual consultation, telephone follow-ups, self-help materials)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Cognitive intervention
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 102
Study: 34038455

Group type: COMPARATOR
Intervention: Information only (active control condition, n = 116)
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Testimonials addressing unspecified audience (arm 2, n = 112)
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Testimonials addressing employees (arm 3, n = 115)
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Testimonials addressing working university students (arm 4, n = 108)
Number of subjects: 451
Study: 32475067

Group type: EXPERIMENTAL
Intervention: Everolimus 1.5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Everolimus 2.25 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Everolimus 3 mg
Number of subjects: 0
Study: 34260473

Group type: EXPERIMENTAL
Intervention: Hyper-perfusion index (HPi)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: HPi≥9.97
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: HPi≥16.25
Number of subjects: 135

Group type: COMPARATOR
Intervention: Non-EAD patients
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Achieving an HPi below target cut-off
Number of subjects: 135
Study: 32900662

Group type: EXPERIMENTAL
Intervention: Single 20-mg dexamethasone tablet (fasting)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Single 20-mg dexamethasone tablet (fed)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Five 4-mg dexamethasone tablets (reference)
Number of subjects: 36
Study: 36302979

Group type: EXPERIMENTAL
Intervention: GeneFolio® Pharmacogenomic Panel (4-week group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GeneFolio® Pharmacogenomic Panel (psychiatrists’ patients)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GeneFolio® Pharmacogenomic Panel
Number of subjects: 0
Study: 33944971

Group type: COMPARATOR
Intervention: Euglycaemia (5 mmol/l) with 20 mU [m2 BSA]‐1 min‐1 insulin (Eu20)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Hyperglycaemia (17 mmol/l) with 20 mU [m2 BSA]‐1 min‐1 insulin (Hyper20)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Hyperglycaemia (17 mmol/l) with 5 mU [m2 BSA]‐1 min‐1 insulin (Hyper5)
Number of subjects: 12
Study: 32310158

Group type: EXPERIMENTAL
Intervention: Lumbosacral immobilization using a custom-made pantaloon cast worn continuously for one week following a GC IDI of 25 mg of prednisolone acetate
Number of subjects: 12

Group type: COMPARATOR
Intervention: GC IDI alone
Number of subjects: 12